阿拉比诺西兰通过调节肠道微生物群和胆汁酸代谢来减轻肥胖症
Jun Lin1, Huiying Liu1, Yonggan Sun2
1Department of Physiology and Pathophysiology, School of Basic Medical Sciences, State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing 100191, China.
食纤维阿拉比诺西兰有效降低了体重,并改善了肥胖小鼠的代谢健康. 它通过调节肠道微生物群,增强肠道屏障功能,改变胆酸和SCFA生产来实现这一目标.
科学领域:
- 微生物学 微生物学
- 营养科学 营养科学
- 代谢健康 代谢健康
背景情况:
- 超重和肥胖是全球重要的公共卫生问题.
- 食纤维摄入与肥胖和相关的代谢障碍相反相关.
- 肠道微生物群在宿主新陈代谢和能量平衡中起着至关重要的作用.
研究的目的:
- 通过检查它对肠道微生态学的影响来研究阿拉比诺西兰对肥胖的影响.
- 阐明阿拉比诺西兰改善肥胖和相关代谢功能障碍的机制.
主要方法:
- 给肥胖小鼠使用阿拉比诺西兰.
- 分析体重,葡萄糖代谢和肠道屏障功能.
- 肠道微生物组成分析 (16S rRNA测序).
- 代谢分析,包括二次胆酸和短链脂肪酸 (SCFA).
主要成果:
- 在肥胖小鼠中,阿拉比诺西兰补充剂显著降低了体重,并改善了葡萄糖代谢.
- 阿拉比诺西兰增强了肠道屏障功能,并减少了代谢性内毒素.
- 阿拉比诺克西兰改变了肠道微生物群的组成,增加了有益细菌,并调高了7α-脱化,导致二次胆汁酸 (脱氧醇酸,石灰醇酸) 变化.
- 肠道微生物群由阿拉比诺基兰的调节影响了SCFA的产生和特定代谢物的水平,如基尼斯,戴兹,酸和酸.
结论:
- 阿拉比诺西兰在小鼠中表现出显著的抗肥胖作用.
- 这些效应通过调节肠道微生物群的组成和功能来调节.
- 阿拉比诺西兰促进有益的生物活性代谢物的产生,有助于改善代谢健康.
更多相关视频
13:09Rapid Model to Evaluate the Anti-Obesity Potential of a Combination of Syzygium aromaticum Clove and Cuminun cyminum Cumin on C57BL6/j Mice Fed High-Fat Diet
Published on: July 31, 2021
07:15An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
Published on: July 31, 2019
相关概念视频
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Drugs for Treatment of Constipation-Predominant IBS
Cholesterol: Significance and Regulation
Considering cholesterol and...
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
